Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock Patients

Launched by SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES · Apr 9, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the connection between a condition called Disseminated Intravascular Coagulation (DIC) and organ dysfunction in patients who are experiencing septic shock. Septic shock is a serious complication that can occur in critically ill patients, particularly in lower and middle-income countries. The researchers want to see how scoring for DIC can help predict which patients might be at greater risk for worsening organ function and help guide early treatment decisions.

To be eligible for the study, patients must be adults in the intensive care unit who have septic shock and require medications to support their blood pressure for at least 12 hours. Those younger than 18 or older than 65 years, as well as patients who have had septic shock for less than 12 hours or more than 24 hours, will not be included. Participants in this trial can expect to undergo monitoring that will help doctors understand how DIC affects their condition. This research is important because it aims to improve care for patients facing these serious health challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult ICU patients having septic shock as defined by Sepsis -3 definition requiring vasopressor for at least 12 hours duration will be considered.
• Exclusion Criteria:
• • Patient having septic shock duration either less than 12 hours or more than 24 hours at the time of the inclusion
• • Age less than 18 years or more than 65 years
• • Expected survival less than 72 hours
• • Caregiver refused for the consent to participate in the study